Global Inhaled Nitric Oxide Market By Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS) and Other Applications), By Region, Industry Analysis and Forecast, 2020 - 2026

The Global Inhaled Nitric Oxide Market size is expected to reach $915.7 Million by 2026, rising at a market growth of 7% CAGR during the forecast period. Nitric oxide is a molecule of gas that causes a sense of relaxation in smooth muscle cells in the vasculature. It is because Nitric Oxide reacts with oxyhemoglobin. The gas is quickly collected by oxyhemoglobin in red blood cells and the vasodilating effects caused by inhaled nitric oxide are restricted to oxygenated areas of the lungs. Thus, this distinct ability of Nitric oxide to cause pulmonary vasodilatation in the oxygenated regions of the lung helps in enhancing oxygenation of the blood and reduces intrapulmonary right to left shunting. Hence, the inhaled nitric oxide is utilized to cure various cardiopulmonary conditions, like pulmonary hypertension in adults and children. Although, the usage of inhaled nitric oxide is restricted due to logistical and financial reasons.

The rising prevalence of diseases in infants like a neonatal hypoxic respiratory failure (HRF) and persistent pulmonary hypertension is among the key driving factors of the market. Moreover, the growing number of patients with chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS) also propel the market growth. Apart from this, the huge cost involved in the treatment & the stringent government policies on different applications of the gas are restricting the growth of Inhaled Nitric Oxide market. However, the constant R&D activities for discovering various new applications in the healthcare sector are estimated to offer profitable opportunities for expanding the global inhaled nitric oxide market during the forecast period.

The declaration of WHO about the Covid-19 outbreak as a public health emergency has affected every country around the globe. During the pandemic, nitric oxide got under several experiments to test whether it can help in treating Covid-19 affected people, due to its antiviral properties and enhanced oxygenation. Inhaled Nitric Oxide is useful in safeguarding the frontline healthcare workers from this pandemic.

Application Outlook

Based on Application, the market is segmented into Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS) and Other Applications. Neonatal respiratory treatment segment procured the substantial revenue share and is estimated to exhibit high growth rate during the forecast period. This is due a surge in the occurrences of diseases in the newborn like persistent pulmonary hypertension, and neonatal hypoxic respiratory failure (HRF). The chronic obstructive pulmonary disease segment would display promising growth rate during the forecast period.

Inhaled Nitric Oxide Market Report Coverage

Report Attribute	Details
Market size value in 2019	USD 581.5 Million
Market size forecast in 2026	USD 915.7 Million
Base Year	2019
Historical Period	2016 to 2018
Forecast Period	2020 to 2026
Revenue Growth Rate	CAGR of 7% from 2020 to 2026
Number of Pages	123
Number of Tables	180
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Application, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Australia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Inhaled nitric oxide helps in curing chronic lung diseases in infants Increasing cases of congenital heart disease
Restraints	High cost associated with the inhaled nitric oxide treatment

Free Valuable Insights: Global Inhaled Nitric Oxide Market to reach a market size of $915.7 million by 2026

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America emerged as the leading region in the global inhaled nitric oxide market in 2019. The high growth of the regional market is due to the large consumer base & rising funding in R&D by the leading players. Major determinants such as surge in rates of chronic diseases in the newborn like persistent pulmonary hypertension, and neonatal hypoxic respiratory failure (HRF) are expected to support the market growth.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Getinge AB, Merck Group, Halma PLC, Linde PLC (Praxair, Inc.), Air Liquide S.A., Beyond Air, Inc., Mallinckrodt PLC (International Minerals and Chemical Corporation), VERO Biotech LLC, Nu-Med Plus, Inc. and Novoteris, LLC.

Recent Strategies Deployed in Inhaled Nitric Oxide Market

• Dec-2020: Beyond Air introduced a pilot clinical trial analyzing its investigational therapy LungFit GO. It is an inhaled nitric oxide, which can be self-administrated at home, in adults with or without cystic fibrosis (CF) those who have chronic, treatment-resistant lung infections caused by non-tuberculosis mycobacteria (NTM).
• Nov-2020: Mallinckrodt announced the beginning of a retrospective chart review study, under the title "Nitric Oxide Treatment In COVID-19 Evaluation (NOTICE)" to accumulate real-world data on the usage of INOmax (nitric oxide) gas, for inhalation therapy in patients with respiratory complications related to the novel coronavirus SARS-CoV-2 (COVID-19).
• Nov-2020: Beyond Air submitted its premarket approval (PMA) application for its LungFit PH to the U.S. Food and Drug Administration (FDA). LungFit PH helps in curing persistent pulmonary hypertension of the newborn (PPHN). FDA guidelines permitted for a 180-day review period for a PMA. LungFit PH produces nitric oxide from ambient air and transmits it to a ventilator making it a safer and more convenient environment for patients and medical staff.
• Oct-2020: Beyond Air announced the beginning of a clinical study of the LungFit system. This system is used for assessment of the safety and efficacy of high concentration inhaled NO given at particular intervals to the hospitalized adults with acute viral pneumonia, including SARS-CoV-2.
• May-2020: Mallinckrodt joined hands with Massachusetts General Hospital. In this collaboration, the companies aimed to analyze the potential advantages of inhaled nitric oxide as a treatment for pulmonary complications in COVID-19 patients. The collaboration also evaluates the benefits of INOmax (nitric oxide) gas in mechanically ventilated patients who have serious Acute Respiratory Syndrome caused by COVID-19.
• Apr-2020: Mallinckrodt and Novoteris got approval by Health Canada for initiating a pilot study of an inhaled formulation of nitric oxide (NO) as a possible treatment for coronavirus. This study was carried out at Vancouver Coastal Health Authority facilities. It has tested a high-concentration form of NO called Thiolanox in development by the companies, delivered by utilizing a specialized Novoteris delivery device.
• Apr-2020: Beyond Air got a clean chit by the U.S. Food and Drug Administration (FDA) for initiating a clinical study in the U.S. using the LungFit TM system to cure COVID-19 patients. Applications for funding were incomplete with the Biomedical Advance Research and Development Authority (BARDA), a division of Health and Human Services (HHS).
• Mar-2020: Beyond Air received an approval from Health Canada to use LungFit system for study in hospitalized patients infected with COVID-19 caused by the serious acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
• Dec-2019: VERO Biotech received an approval of GENOSYL (nitric oxide) gas, for inhalation by the US Food and Drug Administration (FDA). GENOSYL is contraindicated in the process of treating the neonates dependent on right-to-left shunting of blood.
• Jun-2017: Novoteris announced that the US Food and Drug Administration and the Therapeutic Products Directorate of Health Canada have given them a clean chit on its Phase 2 clinical trial application. The company has further initiated recruiting subjects into its Phase 2 trial that used inhaled nitric oxide for the treatment of Cystic Fibrosis (CF).
• Feb-2017: Nu-Med Plus signed a stock agreement with Smith Corporate Services, a professional project management and contact center management consulting firm. The agreement enabled company to continue to move forward by redefining the INO arena and move further on the path to fill for regulatory approval of their products which included their proprietary conversion technology.

Scope of the Study

Market Segments Covered in the Report:

By Application

• Neonatal Respiratory Treatment
• Chronic Obstructive Pulmonary Disease (COPD)
• Acute Respiratory Distress Syndrome (ARDS)
• Other Applications

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Getinge AB
• Merck Group
• Halma PLC
• Linde PLC (Praxair, Inc.)
• Air Liquide S.A.
• Beyond Air, Inc.
• Mallinckrodt PLC (International Minerals and Chemical Corporation)
• VERO Biotech LLC
• Nu-Med Plus, Inc.
• Novoteris, LLC

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Inhaled Nitric Oxide Market, by Application
1.4.2 Global Inhaled Nitric Oxide Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Inhaled Nitric Oxide Market

Chapter 4. Global Inhaled Nitric Oxide Market by Application
4.1 Global Neonatal Respiratory Treatment Repellent Market by Region
4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Region
4.3 Global Acute Respiratory Distress Syndrome (ARDS) Market by Region
4.4 Global Other Applications Market by Region

Chapter 5. Global Inhaled Nitric Oxide Market by Region
5.1 North America Inhaled Nitric Oxide Market
5.1.1 North America Inhaled Nitric Oxide Market by Application
5.1.1.1 North America Neonatal Respiratory Treatment Repellent Market by Country
5.1.1.2 North America Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country
5.1.1.3 North America Acute Respiratory Distress Syndrome (ARDS) Market by Country
5.1.1.4 North America Other Applications Market by Country
5.1.2 North America Inhaled Nitric Oxide Market by Country
5.1.2.1 USA Inhaled Nitric Oxide Market
5.1.2.1.1 USA Inhaled Nitric Oxide Market by Application
5.1.2.2 Canada Inhaled Nitric Oxide Market
5.1.2.2.1 Canada Inhaled Nitric Oxide Market by Application
5.1.2.3 Mexico Inhaled Nitric Oxide Market
5.1.2.3.1 Mexico Inhaled Nitric Oxide Market by Application
5.1.2.4 Rest of North America Inhaled Nitric Oxide Market
5.1.2.4.1 Rest of North America Inhaled Nitric Oxide Market by Application
5.2 Europe Inhaled Nitric Oxide Market
5.2.1 Europe Inhaled Nitric Oxide Market by Application
5.2.1.1 Europe Neonatal Respiratory Treatment Repellent Market by Country
5.2.1.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country
5.2.1.3 Europe Acute Respiratory Distress Syndrome (ARDS) Market by Country
5.2.1.4 Europe Other Applications Market by Country
5.2.2 Europe Inhaled Nitric Oxide Market by Country
5.2.2.1 Germany Inhaled Nitric Oxide Market
5.2.2.1.1 Germany Inhaled Nitric Oxide Market by Application
5.2.2.2 UK Inhaled Nitric Oxide Market
5.2.2.2.1 UK Inhaled Nitric Oxide Market by Application
5.2.2.3 France Inhaled Nitric Oxide Market
5.2.2.3.1 France Inhaled Nitric Oxide Market by Application
5.2.2.4 Russia Inhaled Nitric Oxide Market
5.2.2.4.1 Russia Inhaled Nitric Oxide Market by Application
5.2.2.5 Spain Inhaled Nitric Oxide Market
5.2.2.5.1 Spain Inhaled Nitric Oxide Market by Application
5.2.2.6 Italy Inhaled Nitric Oxide Market
5.2.2.6.1 Italy Inhaled Nitric Oxide Market by Application
5.2.2.7 Rest of Europe Inhaled Nitric Oxide Market
5.2.2.7.1 Rest of Europe Inhaled Nitric Oxide Market by Application
5.3 Asia Pacific Inhaled Nitric Oxide Market
5.3.1 Asia Pacific Inhaled Nitric Oxide Market by Application
5.3.1.1 Asia Pacific Neonatal Respiratory Treatment Repellent Market by Country
5.3.1.2 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country
5.3.1.3 Asia Pacific Acute Respiratory Distress Syndrome (ARDS) Market by Country
5.3.1.4 Asia Pacific Other Applications Market by Country
5.3.2 Asia Pacific Inhaled Nitric Oxide Market by Country
5.3.2.1 China Inhaled Nitric Oxide Market
5.3.2.1.1 China Inhaled Nitric Oxide Market by Application
5.3.2.2 India Inhaled Nitric Oxide Market
5.3.2.2.1 India Inhaled Nitric Oxide Market by Application
5.3.2.3 Japan Inhaled Nitric Oxide Market
5.3.2.3.1 Japan Inhaled Nitric Oxide Market by Application
5.3.2.4 South Korea Inhaled Nitric Oxide Market
5.3.2.4.1 South Korea Inhaled Nitric Oxide Market by Application
5.3.2.5 Singapore Inhaled Nitric Oxide Market
5.3.2.5.1 Singapore Inhaled Nitric Oxide Market by Application
5.3.2.6 Australia Inhaled Nitric Oxide Market
5.3.2.6.1 Australia Inhaled Nitric Oxide Market by Application
5.3.2.7 Rest of Asia Pacific Inhaled Nitric Oxide Market
5.3.2.7.1 Rest of Asia Pacific Inhaled Nitric Oxide Market by Application
5.4 LAMEA Inhaled Nitric Oxide Market
5.4.1 LAMEA Inhaled Nitric Oxide Market by Application
5.4.1.1 LAMEA Neonatal Respiratory Treatment Repellent Market by Country
5.4.1.2 LAMEA Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country
5.4.1.3 LAMEA Acute Respiratory Distress Syndrome (ARDS) Market by Country
5.4.1.4 LAMEA Other Applications Market by Country
5.4.2 LAMEA Inhaled Nitric Oxide Market by Country
5.4.2.1 Brazil Inhaled Nitric Oxide Market
5.4.2.1.1 Brazil Inhaled Nitric Oxide Market by Application
5.4.2.2 Argentina Inhaled Nitric Oxide Market
5.4.2.2.1 Argentina Inhaled Nitric Oxide Market by Application
5.4.2.3 UAE Inhaled Nitric Oxide Market
5.4.2.3.1 UAE Inhaled Nitric Oxide Market by Application
5.4.2.4 Saudi Arabia Inhaled Nitric Oxide Market
5.4.2.4.1 Saudi Arabia Inhaled Nitric Oxide Market by Application
5.4.2.5 South Africa Inhaled Nitric Oxide Market
5.4.2.5.1 South Africa Inhaled Nitric Oxide Market by Application
5.4.2.6 Nigeria Inhaled Nitric Oxide Market
5.4.2.6.1 Nigeria Inhaled Nitric Oxide Market by Application
5.4.2.7 Rest of LAMEA Inhaled Nitric Oxide Market
5.4.2.7.1 Rest of LAMEA Inhaled Nitric Oxide Market by Application

Chapter 6. Company Profiles
6.1 Getinge AB
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.2 Merck Group
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Halma PLC
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Linde PLC (Praxair, Inc.)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Acquisition and Mergers:
6.5 Air Liquide S.A.
6.5.1 Company Overview
6.5.1 Financial Analysis
6.6 Beyond Air, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Research & Development Expense
6.6.4 Recent strategies and developments:
6.6.4.1 Trials and Approvals:
6.7 Mallinckrodt PLC (International Minerals and Chemical Corporation)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Trials and Approvals:
6.7.5.2 Partnerships, Collaborations, and Agreements:
6.8 VERO Biotech LLC
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Trials and Approvals:
6.9 Nu-Med Plus, Inc.
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. Novoteris, LLC
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Trials and Approvals:

TABLE 1 Global Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 2 Global Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 3 Global Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 4 Global Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 5 Global Neonatal Respiratory Treatment Repellent Market by Region, 2016 - 2019, USD Million
TABLE 6 Global Neonatal Respiratory Treatment Repellent Market by Region, 2020 - 2026, USD Million
TABLE 7 Global Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Region, 2016 - 2019, USD Million
TABLE 8 Global Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Region, 2020 - 2026, USD Million
TABLE 9 Global Acute Respiratory Distress Syndrome (ARDS) Market by Region, 2016 - 2019, USD Million
TABLE 10 Global Acute Respiratory Distress Syndrome (ARDS) Market by Region, 2020 - 2026, USD Million
TABLE 11 Global Other Applications Market by Region, 2016 - 2019, USD Million
TABLE 12 Global Other Applications Market by Region, 2020 - 2026, USD Million
TABLE 13 Global Inhaled Nitric Oxide Market by Region, 2016 - 2019, USD Million
TABLE 14 Global Inhaled Nitric Oxide Market by Region, 2020 - 2026, USD Million
TABLE 15 North America Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 16 North America Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 17 North America Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 18 North America Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 19 North America Neonatal Respiratory Treatment Repellent Market by Country, 2016 - 2019, USD Million
TABLE 20 North America Neonatal Respiratory Treatment Repellent Market by Country, 2020 - 2026, USD Million
TABLE 21 North America Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2016 - 2019, USD Million
TABLE 22 North America Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2020 - 2026, USD Million
TABLE 23 North America Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2016 - 2019, USD Million
TABLE 24 North America Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2020 - 2026, USD Million
TABLE 25 North America Other Applications Market by Country, 2016 - 2019, USD Million
TABLE 26 North America Other Applications Market by Country, 2020 - 2026, USD Million
TABLE 27 North America Inhaled Nitric Oxide Market by Country, 2016 - 2019, USD Million
TABLE 28 North America Inhaled Nitric Oxide Market by Country, 2020 - 2026, USD Million
TABLE 29 USA Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 30 USA Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 31 USA Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 32 USA Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 33 Canada Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 34 Canada Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 35 Canada Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 36 Canada Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 37 Mexico Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 38 Mexico Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 39 Mexico Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 40 Mexico Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 41 Rest of North America Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 42 Rest of North America Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 43 Rest of North America Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 44 Rest of North America Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 45 Europe Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 46 Europe Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 47 Europe Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 48 Europe Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 49 Europe Neonatal Respiratory Treatment Repellent Market by Country, 2016 - 2019, USD Million
TABLE 50 Europe Neonatal Respiratory Treatment Repellent Market by Country, 2020 - 2026, USD Million
TABLE 51 Europe Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2016 - 2019, USD Million
TABLE 52 Europe Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2020 - 2026, USD Million
TABLE 53 Europe Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2016 - 2019, USD Million
TABLE 54 Europe Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2020 - 2026, USD Million
TABLE 55 Europe Other Applications Market by Country, 2016 - 2019, USD Million
TABLE 56 Europe Other Applications Market by Country, 2020 - 2026, USD Million
TABLE 57 Europe Inhaled Nitric Oxide Market by Country, 2016 - 2019, USD Million
TABLE 58 Europe Inhaled Nitric Oxide Market by Country, 2020 - 2026, USD Million
TABLE 59 Germany Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 60 Germany Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 61 Germany Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 62 Germany Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 63 UK Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 64 UK Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 65 UK Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 66 UK Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 67 France Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 68 France Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 69 France Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 70 France Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 71 Russia Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 72 Russia Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 73 Russia Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 74 Russia Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 75 Spain Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 76 Spain Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 77 Spain Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 78 Spain Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 79 Italy Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 80 Italy Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 81 Italy Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 82 Italy Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 83 Rest of Europe Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 84 Rest of Europe Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 85 Rest of Europe Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 86 Rest of Europe Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 87 Asia Pacific Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 88 Asia Pacific Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 89 Asia Pacific Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 90 Asia Pacific Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 91 Asia Pacific Neonatal Respiratory Treatment Repellent Market by Country, 2016 - 2019, USD Million
TABLE 92 Asia Pacific Neonatal Respiratory Treatment Repellent Market by Country, 2020 - 2026, USD Million
TABLE 93 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2016 - 2019, USD Million
TABLE 94 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2020 - 2026, USD Million
TABLE 95 Asia Pacific Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2016 - 2019, USD Million
TABLE 96 Asia Pacific Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2020 - 2026, USD Million
TABLE 97 Asia Pacific Other Applications Market by Country, 2016 - 2019, USD Million
TABLE 98 Asia Pacific Other Applications Market by Country, 2020 - 2026, USD Million
TABLE 99 Asia Pacific Inhaled Nitric Oxide Market by Country, 2016 - 2019, USD Million
TABLE 100 Asia Pacific Inhaled Nitric Oxide Market by Country, 2020 - 2026, USD Million
TABLE 101 China Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 102 China Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 103 China Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 104 China Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 105 India Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 106 India Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 107 India Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 108 India Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 109 Japan Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 110 Japan Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 111 Japan Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 112 Japan Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 113 South Korea Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 114 South Korea Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 115 South Korea Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 116 South Korea Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 117 Singapore Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 118 Singapore Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 119 Singapore Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 120 Singapore Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 121 Australia Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 122 Australia Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 123 Australia Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 124 Australia Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 125 Rest of Asia Pacific Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 126 Rest of Asia Pacific Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 127 Rest of Asia Pacific Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 128 Rest of Asia Pacific Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 129 LAMEA Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 130 LAMEA Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 131 LAMEA Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 132 LAMEA Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 133 LAMEA Neonatal Respiratory Treatment Repellent Market by Country, 2016 - 2019, USD Million
TABLE 134 LAMEA Neonatal Respiratory Treatment Repellent Market by Country, 2020 - 2026, USD Million
TABLE 135 LAMEA Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2016 - 2019, USD Million
TABLE 136 LAMEA Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2020 - 2026, USD Million
TABLE 137 LAMEA Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2016 - 2019, USD Million
TABLE 138 LAMEA Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2020 - 2026, USD Million
TABLE 139 LAMEA Other Applications Market by Country, 2016 - 2019, USD Million
TABLE 140 LAMEA Other Applications Market by Country, 2020 - 2026, USD Million
TABLE 141 LAMEA Inhaled Nitric Oxide Market by Country, 2016 - 2019, USD Million
TABLE 142 LAMEA Inhaled Nitric Oxide Market by Country, 2020 - 2026, USD Million
TABLE 143 Brazil Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 144 Brazil Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 145 Brazil Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 146 Brazil Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 147 Argentina Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 148 Argentina Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 149 Argentina Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 150 Argentina Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 151 UAE Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 152 UAE Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 153 UAE Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 154 UAE Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 155 Saudi Arabia Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 156 Saudi Arabia Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 157 Saudi Arabia Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 158 Saudi Arabia Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 159 South Africa Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 160 South Africa Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 161 South Africa Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 162 South Africa Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 163 Nigeria Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 164 Nigeria Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 165 Nigeria Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 166 Nigeria Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 167 Rest of LAMEA Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 168 Rest of LAMEA Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 169 Rest of LAMEA Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 170 Rest of LAMEA Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 171 Key Information – Getinge AB
TABLE 172 key Information – Merck Group
TABLE 173 key Information – Halma PLC
TABLE 174 key Information – Linde PLC
TABLE 175 Key information – Air Liquide S.A.
TABLE 176 Key information – Beyond Air, Inc.
TABLE 177 Key information – Mallinckrodt PLC
TABLE 178 Key Information – VERO Biotech LLC
TABLE 179 key Information – Nu-Med Plus, Inc.
TABLE 180 key Information –Novoteris, LLC

List of Figures
FIG 1 Methodology for the research